News/Dow Jones Newswires/Azora Therapeutics Establishes Bd of Directors With Extensive Drug Development and Inflammatory Bowel Disease ExpertiseFlashAzora Therapeutics Establishes Bd of Directors With Extensive Drug Development and Inflammatory Bowel Disease ExpertiseAZRThis news item displays a headline only and has no other text.Dow Jones NewswiresManagementUS stocks© 2026 Dow Jones & Company, Inc. All rights reserved.Show more
